Actin was served as a launching control. induces transcription inhibition1, 2 . On the other hand, the effect of histone customization on gene expression is usually complex due to histone protein can go through many post-translational modifications (PTM) including phosphorylation, acetylation, methylation, sumoylation, ubiquitination, etc . In addition , the effect of PTM upon transcriptional activity is dependent within the residues altered, the location with the modifications happened and the degree of modification3, four, 5. For example , the lysine residues of histone H3 can be mono-, di-, or tri-methyled (m1, m2, and m3) by different histone methyltransferase (KMTs). Methylation upon lysine four (H3K4) or 36 (H3K36) is usually associated with transcriptional activation while H3K9 and H3K27 methylation are frequently linked with gene silencing and therefore are hallmarks of chromatin condensation5, 6, 7, 8. Latest studies show that the crosstalk between distinct histone adjustments orchestrated by histone changing enzymes is critical to fine-tune gene transcription to fit the physiological demands and to mediate the pathological changes of cells. HSP70-IN-1 H3K27 demethylase KDM6A up-regulated gene expression programs associated with development and attack of breast cancer cells9. Oddly enough, a cohort of the KDM6A-regulated genes is additionally targets with the H3K4 methyltransferase MLL4. The authors demonstrated that KDM6A directly Spry1 interacts with the c-terminal region of MLL4 and the coordinated regulation of gene transcription by MLL4 and KDM6A promotes proliferation and attack of breast cancer cells. One more elegant HSP70-IN-1 research revealed a novel mechanism of the coordinated H3K4 methylation/H3K9 demethylation in the control of gene expression10. In vivo, those two histone markers are mutually exclusive. Immunoprecipitation and mass spectrometry analysis demonstrated that H3K9 trimethyl demethylase JMJD2B is a component of the mixed-lineage leukemia (MLL) 2 complicated, a H3K4-specific methyltransferase. Practical characterization with the JMJD2/MLL2 complicated showed this complex could be co-purified with estrogen receptor and is essential for estrogen receptor -mediated transcription. The interplay between two repression complexes to stimulate gene silencing has recently demonstrated by the research of the H3K9 methyltransferase G9a and the H3K27 methyltransferase complicated PRC211. G9a is a HSP70-IN-1 essential methyltransferase to introduce mono- and di-methylation of H3K9. Although G9a has been shown to methylate H3K27in vitro, whether G9a could directly methylate H3K27in vivois still controversial. Mozzettaet ing. 11demonstrated that G9a literally interacts with PRC2 and modulates PRC2 genomic recruitment to specific focus on genes to improve H3K27 trimethylation at genomic loci. These results give a molecular basis by which G9a controls H3K27 methylation through direct coupling with PRC2. Here, we revealed a novel mechanism by which G9a coordinates the expression of various histone modifying enzymes to promote H3K27 methylation and also to inhibit gene transcription. == Results == == G9a induces H3K9 and H3K27 methylation and downregulates E-cadherin in pancreatic cancer cells == We had previously founded a gemcitabine-resistant cell brand (PANC-1-R) from your parental individual PANC-1 pancreatic cancer cells12. Although PANC-1-R cells are highly resistant to JEWEL and show high invasive characteristic (as shown below), the proliferation rate of such two cell lines is similar suggesting the phenotypic modifications are not associated with their development activity (Supplementary Fig. S1). We identified that manifestation of G9a was considerably up-regulated in PANC-1-R cells (Supplementary Fig. S2). Oddly enough, the methylation of H3K9 and H3K27 was also increased in PANC-1-R cells (Supplementary Fig. S2). Those two cell lines are of similar genetic background and give a good unit for practical study of G9a. Overexpression of G9a in individual pancreatic ductal epithelial cells (HPDE) and PANC-1 cells changed morphology from epithelial type to mesenchymal (spindle-like) phenotype (Fig. 1A). On the other hand, PANC-1-R cells exhibited mesenchymal phenotype and the depletion of G9a.